Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study.

Lin, F Y; Philips, J B; Azimi, P H; Weisman, L E; Clark, P; Rhoads, G G; Regan, J; Concepcion, N F; Frasch, C E; Troendle, J; Brenner, R A; Gray, B M; Bhushan, R; Fitzgerald, G; Moyer, P; Clemens, J D

Lin, F Y; Philips, J B; Azimi, P H; Weisman, L E; Clark, P; Rhoads, G G; Regan, J; Concepcion, N F; Frasch, C E; Troendle, J; Brenner, R A; Gray, B M; Bhushan, R; Fitzgerald, G; Moyer, P; Clemens, J D.

Affiliation

Lin FY; National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892-7510, USA. Link@exchange.nih.gov

J Infect Dis ; 184(8): 1022-8, 2001 Oct 15.

Article in En | MEDLINE | ID: mdl-11574917

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Streptococcal Infections / Streptococcus agalactiae / Immunity, Maternally-Acquired / Antibodies, Bacterial Type of study: Clinical_trials / Prognostic_studies Limits: Female / Humans / Newborn / Pregnancy Language: En Journal: J Infect Dis Year: 2001 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Search on Google

Add to My VHL

XML

PubMed Links